Orthoclone OKT3

muromonab-CD3 · Ortho Biotech (Johnson & Johnson)

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Orthoclone OKT3, covering 2009-02-04 to 2017-06-14. Get the full timeline:

Most recent: Clinical Trial Update: Oral OKT3 for the Treatment of Active Ulcerative Colitis [Phase 1, Phase 2]